Page last updated: 2024-11-05

zolpidem and Acute Relapsing Multiple Sclerosis

zolpidem has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research Excerpts

ExcerptRelevanceReference
"Zolpidem may improve symptoms of spasticity in high doses via affection of GABA alpha2-receptor and alpha3-receptor subunits."1.36Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity. ( Damm, J; Eser, D; Moeller, HJ; Rupprecht, R, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damm, J1
Eser, D1
Moeller, HJ1
Rupprecht, R1

Other Studies

1 other study available for zolpidem and Acute Relapsing Multiple Sclerosis

ArticleYear
Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2

    Topics: Female; GABA Agonists; Humans; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Muscle Spastici

2010